Strong operating performance and high sales prices have delivered record group revenue4 for the quarter of approximately US$337 million and a group gross operating cash margin1 of approximately US$292 million (~A$0.67/share for the June quarter)
EBIT0.67c x 4$2.68 per shareStandard multiple of P/e (x16)$42 per share ?
has anyone run some back of the envelope numbers with stage 2 operating and feed stock going to Narah at 75% ownership?
not advice
- Forums
- ASX - By Stock
- AKE
- Allkem General Discussion
Allkem General Discussion, page-1738
Featured News
Add AKE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online